BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15262122)

  • 1. The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer.
    Alvarez Secord A; Sayer R; Snyder SA; Broadwater G; Rodriguez GC; Berchuck A; Blackwell K
    Gynecol Oncol; 2004 Jul; 94(1):74-9. PubMed ID: 15262122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
    Juretzka MM; Barakat RR; Chi DS; Iasonos A; Dupont J; Abu-Rustum NR; Poynor EA; Aghajanian C; Spriggs D; Hensley ML; Sabbatini P
    Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of preoperative serum vascular endothelial growth factor level with CA125 level in patients with epithelial ovarian cancer and its prognostic value].
    Tan XJ; Lang JH; Shen K; Wang L; Wu M; Xu XY
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):9-12. PubMed ID: 18366924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.
    Chen CA; Cheng WF; Lee CN; Chen TM; Kung CC; Hsieh FJ; Hsieh CY
    Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy?
    Linasmita V; Wilailak S; Thakkinstian A; Srisupundit S; Tangtrakul S; Israngura N; Bullangpoti S
    J Med Assoc Thai; 2001 Jul; 84(7):958-65. PubMed ID: 11759976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer.
    Hefler LA; Zeillinger R; Grimm C; Sood AK; Cheng WF; Gadducci A; Tempfer CB; Reinthaller A
    Gynecol Oncol; 2006 Nov; 103(2):512-7. PubMed ID: 16750560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring cancer antigen 125 levels in induction chemotherapy for epithelial ovarian carcinoma and predicting outcome of second-look procedure.
    Folk JJ; Botsford M; Musa AG
    Gynecol Oncol; 1995 May; 57(2):178-82. PubMed ID: 7729730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of second look laparotomy and secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients.
    Obermair A; Sevelda P
    Acta Obstet Gynecol Scand; 2001 May; 80(5):432-6. PubMed ID: 11328220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of failures after negative second-look in patients with advanced ovarian cancer: an Italian multicenter study.
    Gadducci A; Sartori E; Maggino T; Zola P; Landoni F; Fanucchi A; Palai N; Alessi C; Ferrero AM; Cosio S; Cristofani R
    Gynecol Oncol; 1998 Feb; 68(2):150-5. PubMed ID: 9514797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
    Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer.
    Bozkurt N; Yuce K; Basaran M; Kose F; Ayhan A
    Obstet Gynecol; 2004 Jan; 103(1):82-5. PubMed ID: 14704249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
    Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
    Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer.
    Kang WD; Choi HS; Kim SM
    Gynecol Oncol; 2010 Jan; 116(1):57-60. PubMed ID: 19818996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival.
    Friedman RL; Eisenkop SM; Wang HJ
    Gynecol Oncol; 1997 Oct; 67(1):88-94. PubMed ID: 9345362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome.
    Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Ciampi B; Prontera C; Genazzani AR
    Anticancer Res; 1999; 19(2B):1401-5. PubMed ID: 10365113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer.
    Steffensen KD; Waldstrøm M; Brandslund I; Jakobsen A
    Gynecol Oncol; 2010 Apr; 117(1):109-16. PubMed ID: 20056267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High serum levels of vascular endothelial growth factor predict poor response to transarterial chemoembolization in hepatocellular carcinoma: a prospective study.
    Poon RT; Lau C; Yu WC; Fan ST; Wong J
    Oncol Rep; 2004 May; 11(5):1077-84. PubMed ID: 15069550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
    Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
    Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: a population-based study.
    van Altena AM; Kolwijck E; Spanjer MJ; Hendriks JC; Massuger LF; de Hullu JA
    Gynecol Oncol; 2010 Nov; 119(2):265-9. PubMed ID: 20797777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.